| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Egros Fabrice is a Director at Syndax Pharmaceuticals Inc. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $618K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 14,030 | $18.03 | $252,993.17 | -30.5% | -7.1% | +23.9% | |
| Aug 18, 2021 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 15,635 | $15.75 | $246,327.86 | -49.4% | +17.2% | +54.7% | |
| May 18, 2021 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 13,609 | $18.65 | $253,783.35 | -28.8% | -14.8% | -26.1% | |
| Mar 1, 2021 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 10,241 | $24.31 | $248,981.24 | -24.2% | - | - |